Literature DB >> 15793263

ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes.

Nicola Abate1, Manisha Chandalia, Pankaj Satija, Beverley Adams-Huet, Scott M Grundy, Sreedharan Sandeep, Venkatesan Radha, Raj Deepa, Viswanathan Mohan.   

Abstract

Genetic susceptibility modulates the impact of obesity on risk for type 2 diabetes. The present study evaluates the role of ENPP1 K121Q polymorphism in prediction of type 2 diabetes in three populations that differ in susceptibility to diabetes and environmental exposure. The three cohorts included 679 nonmigrant South Asians living in Chennai, India (223 with type 2 diabetes); 1,083 migrant South Asians living in Dallas, Texas (121 with type 2 diabetes); and 858 nonmigrant Caucasians living in Dallas, Texas (141 with type 2 diabetes). Patients with type 2 diabetes were included in these cohorts if they had diabetes onset before the age of 60 years. The prevalence of subjects carrying the polymorphic ENPP1 121Q allele was 25% in the nondiabetic group and 34% in the diabetic group of South Asians living in Chennai (P = 0.01). The prevalence in the nondiabetic and diabetic groups were 33 and 45% (P = 0.01) for the South Asians living in Dallas and 26 and 39% (P = 0.003) for the Caucasians. Although further replication studies are necessary to test the validity of the described genotype-phenotype relationship, our study supports the hypothesis that ENPP1 121Q predicts genetic susceptibility to type 2 diabetes in both South Asians and Caucasians.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15793263     DOI: 10.2337/diabetes.54.4.1207

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  50 in total

1.  The Genetic Basis of Type 2 Diabetes.

Authors:  Swapan Kumar Das; Steven C Elbein
Journal:  Cellscience       Date:  2006-04-30

2.  Association of the Q121 variant of ENPP1 gene with decreased kidney function among patients with type 2 diabetes.

Authors:  Salvatore De Cosmo; Antonio Minenna; Yuan-Yuan Zhang; Ryan Thompson; Robert Thompson; Giuseppe Miscio; Monica Vedovato; Anna Rauseo; Alois Saller; Sandra Mastroianno; Fabio Pellegrini; Roberto Trevisan; Paola Fioretto; Alessandro Doria; Vincenzo Trischitta
Journal:  Am J Kidney Dis       Date:  2008-10-31       Impact factor: 8.860

Review 3.  Metabolic syndrome components in murine models.

Authors:  Heather A Lawson; James M Cheverud
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-03       Impact factor: 2.895

4.  The ENPP1 K121Q polymorphism determines individual susceptibility to the insulin-sensitising effect of lifestyle intervention.

Authors:  K Müssig; M Heni; C Thamer; K Kantartzis; F Machicao; N Stefan; A Fritsche; H-U Häring; H Staiger
Journal:  Diabetologia       Date:  2009-11-29       Impact factor: 10.122

Review 5.  Clinical review: the genetics of type 2 diabetes: a realistic appraisal in 2008.

Authors:  Jose C Florez
Journal:  J Clin Endocrinol Metab       Date:  2008-09-09       Impact factor: 5.958

6.  Association of genetic variation in ENPP1 with obesity-related phenotypes.

Authors:  Christopher P Jenkinson; Dawn K Coletta; Marion Flechtner-Mors; Shirley L Hu; Marcel J Fourcaudot; Lenore M Rodriguez; Jennifer Schneider; Rector Arya; Michael P Stern; John Blangero; Ravindranath Duggirala; Ralph A DeFronzo
Journal:  Obesity (Silver Spring)       Date:  2008-05-08       Impact factor: 5.002

Review 7.  Principles and practice of nonpharmacological interventions to reduce cardiometabolic risk.

Authors:  Samuel Dagogo-Jack; Nonso Egbuonu; Chimaroke Edeoga
Journal:  Med Princ Pract       Date:  2010-03-29       Impact factor: 1.927

8.  Quinazoline-4-piperidine sulfamides are specific inhibitors of human NPP1 and prevent pathological mineralization of valve interstitial cells.

Authors:  Elnur Elyar Shayhidin; Elsa Forcellini; Marie-Chloé Boulanger; Ablajan Mahmut; Sébastien Dautrey; Xavier Barbeau; Patrick Lagüe; Jean Sévigny; Jean-François Paquin; Patrick Mathieu
Journal:  Br J Pharmacol       Date:  2015-07-08       Impact factor: 8.739

9.  Hepatic ENPP1 expression is induced in diabetic rabbits.

Authors:  Philipp Eller; Kathrin Hochegger; Andreas Wehinger; Ivan Tancevski; Wilfried Schgoer; Andreas Ritsch; Josef R Patsch
Journal:  Mamm Genome       Date:  2006-08-04       Impact factor: 2.957

10.  The K121Q polymorphism of ENPP1 and peripheral arterial disease.

Authors:  Philipp Eller; Wilfried Schgoer; Thomas Mueller; Ivan Tancevski; Egon Demetz; Kristina Duwensee; Andreas Ritsch; Meinhard Haltmayer; Josef R Patsch
Journal:  Heart Vessels       Date:  2008-04-04       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.